Vaccination by recombinant yeast by generating a protective humoral immune response against defined antigens
DE102011105694A1
Cellular proteins ("host factors"), which are essential for the propagation of RNA viruses
DE102011002649A1
Optoelectronic semiconductor component e.g. photovoltaic cell, for converting incoming optical radiation into electrical energy, has substrate provided with sides and pores, and material arranged in pores
DE102009060102A1
Derivatization reagents for the tandem mass spectrometric quantification of proteins
DE102009057698A1
Bioreactor for multi-dimensional, mechanical stimulation of cells, cell complexes and/or cell tissue, comprises a first and a second reactor part volumes that are separated from each other through a carrier membrane
DE102009042321A1
Method for manufacturing n-doped silicon body utilized in article for e.g. electrical purposes to determine chemical molecules, involves manufacturing body from crystalline Neutron-Transmutation-Doped silicon
DE102009031733A1
Method for risk stratification of cancer patients identified with cancer disease, involves determining risk of potential of blood samples subjected to fluorescence study
DE102008057451A1
Method for oral vaccination by means of recombinant yeasts
DE102008056434A1
Method for verifying systems assembled from software components, involves bringing together software components to system abstractions for verification, where verifying conditions for software components are loaded
DE102008050588A1
Immobilized monomeric avidin monolithic column for enrichment and identification of biotinylated species
DE102008027261A1
Process for improving the physico-chemical properties of biodegradable materials
DE102007042727A1
Thermostable transglutaminases
DE102007037989A1
Percutaneous transluminal coronary angioplasty-guiding catheter for transcoronary myocardial stimulation during coronary intervention, has electrode integrated into catheter through coil or through vaporization of conductor
DE102007009401A1
Synergist effective during tauopathy comprises 1-aza-9-oxafluorene compound
DE102006056731A1
Process for the production of elemental mercury from mercury compounds
DE102006044199A1
Producing a storage-stable pharmaceutical product comprises encapsulating an amorphous medicament in a nanostructured organic or inorganic host system
DE102006032176A1
Method for concentrating dissolved material comprises directionally separating out the solvent contained in the material by freezing until the required concentration is reached
DE102006020444A1
Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors
DE102006020307A1
Transgenic mesenchymal stem cells stably expressing tumor necrosis factor-related apoptosis-inducing ligand, e.g. useful for treating tumors
DE102006014825A1
Circuit arrangement and method for the voltametric signal processing of biosensors
